摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

2-oxopropanal (4-methylphenyl)hydrazone | 18804-66-5

中文名称
——
中文别名
——
英文名称
2-oxopropanal (4-methylphenyl)hydrazone
英文别名
1-[2-(4-methylphenyl)hydrazinylidene]propan-2-one;1-(2-(p-tolyl)hydrazono)propan-2-one;Methylglyoxal-p-tolylhydrazon;1-(p-tolyl-hydrazono)-propan-2-one;β-Oxo-α-p-toolylhydrazono-propan;pyruvaldehyde-1-p-tolylhydrazone;Methylglyoxal-ω-p-tolylhydazon;Pyruvaldehyd-1-p-tolylhydrazon;Acetonyliden-p-tolylhydrazin;1-[(4-Methylphenyl)hydrazinylidene]propan-2-one;1-[(4-methylphenyl)hydrazinylidene]propan-2-one
2-oxopropanal (4-methylphenyl)hydrazone化学式
CAS
18804-66-5
化学式
C10H12N2O
mdl
——
分子量
176.218
InChiKey
UFVKXRCBBFGXKO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    128-130 °C(Solv: toluene (108-88-3))
  • 沸点:
    284.0±33.0 °C(Predicted)
  • 密度:
    1.03±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.98
  • 重原子数:
    13.0
  • 可旋转键数:
    3.0
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    41.46
  • 氢给体数:
    1.0
  • 氢受体数:
    3.0

SDS

SDS:7a0cf92803743354cc9c0d934e4f8192
查看

反应信息

点击查看最新优质反应信息

文献信息

  • Behaviour of Arylazo tert-Butyl Sulfides with Ketone Enolates. Competition between SRN1 α-arylation and Azocoupling Reactions.
    作者:Carlo Dell'Erba、Marino Novi、Giovanni Petrillo、Cinzia Tavani
    DOI:10.1016/s0040-4020(01)88144-8
    日期:——
    room temperature, with potassium acetone enolate to give good yields of 1-aryl-2-propanones via spontaneous SRN1 dark reactions, α-Phenylation of pinacolone and acetophenone enolates by 1a likewise occurs in excellent yields. In agreement with the involvement of an electron-transfer catalyzed chain process, the reaction of the 4-bromo derivative 1n with pinacolone enolate gives mainly the bis-substitution
    (Z)-芳基偶氮叔丁基硫化物1a-i在DMSO中和室温下与丙酮烯醇钾反应,通过自发的S RN 1暗反应,频哪酮的α-苯甲酰化反应生成1-芳基-2-丙烷的良好收率苯乙酮烯醇化1a的收率也很高。与电子转移催化链过程的参与相一致,4-溴衍生物1n与频哪酮烯醇酸酯的反应主要产生双取代产物13。在偶氮硫化物1j–m中,芳基化途径与碱基诱导的硫醇消除竞争,最终取决于偶氮硫化物的结构而导致吲唑8或11和/或2-氧代丙醛芳基腙9,10或12。
  • New Multifunctional Agents for Potential Alzheimer’s Disease Treatment Based on Tacrine Conjugates with 2-Arylhydrazinylidene-1,3-Diketones
    作者:Natalia A. Elkina、Maria V. Grishchenko、Evgeny V. Shchegolkov、Galina F. Makhaeva、Nadezhda V. Kovaleva、Elena V. Rudakova、Natalia P. Boltneva、Sofya V. Lushchekina、Tatiana Y. Astakhova、Eugene V. Radchenko、Vladimir A. Palyulin、Ekaterina F. Zhilina、Anastasiya N. Perminova、Luka S. Lapshin、Yanina V. Burgart、Victor I. Saloutin、Rudy J. Richardson
    DOI:10.3390/biom12111551
    日期:——
    development of new effective therapeutic agents for AD is one of the most urgent and challenging tasks. To address this need, we used an aminoalkylene linker to combine the well-known anticholinesterase drug tacrine with antioxidant 2-tolylhydrazinylidene-1,3-diketones to create 3 groups of hybrid compounds as new multifunctional agents with the potential for AD treatment. Lead compounds of the new conjugates
    阿尔茨海默病 (AD) 被认为是一种现代流行病,因为它在全球范围内的患病率不断上升,并产生严重的医学社会后果,包括治疗和患者护理的经济负担。开发新的有效治疗AD的药物是最紧迫和最具挑战性的任务之一。为了满足这一需求,我们使用氨基亚烷基连接体将著名的抗胆碱酯酶药物他克林与抗氧化剂 2-甲苯基亚肼基-1,3-二酮结合起来,创建了 3 组杂合化合物,作为具有 AD 治疗潜力的新型多功能药物。新缀合物的先导化合物可有效抑制乙酰胆碱酯酶(AChE,IC 50 0.24–0.34 µM)和丁酰胆碱酯酶(BChE,IC 50 0.036–0.0745 µM),对脱靶羧酸酯酶的抑制较弱。抗AChE活性随着亚烷基间隔基的延长而增加,这与分子对接一致,这表明化合物与AChE的催化活性位点和外周阴离子位点(PAS)结合,这与混合型可逆抑制一致。 PAS 结合以及有效的丙啶置换表明该杂交体具有阻断 AChE 诱导的
  • Shmelev, L. V.; Lipunova, G. N.; Sulim, O. P., Journal of general chemistry of the USSR, 1986, vol. 56, p. 2114 - 2121
    作者:Shmelev, L. V.、Lipunova, G. N.、Sulim, O. P.、Bednyagina, N. P.
    DOI:——
    日期:——
  • Weygand et al., Chemische Berichte, 1955, vol. 88, p. 487,497
    作者:Weygand et al.
    DOI:——
    日期:——
  • Synthesis, spectroscopic characterization and biological activity on newly synthesized copper(II) and nickel(II) complexes incorporating bidentate oxygen–nitrogen hydrazone ligands
    作者:Ahmed A. El-Sherif
    DOI:10.1016/j.ica.2009.08.004
    日期:2009.11
    We report the synthesis of the hydrazone ligands, 1-(phenyl-hydrazono)-propan-2-one (PHP), 1-(p-tolylhydrazono)-propan-2-one (THP), 1-[(4- chloro-hydrazono)]-propan-2-one (CHP), and their Ni(II) and Cu(II) metal complexes. The structure of the ligands and their complexes were investigated using elemental analysis, magnetic susceptibility, molar conductance and spectral (IR, UV, and EPR) measurements. IR spectra indicate that the free ligands exist in the hydrazo-ketone rather than azo-enol form in the solid state. Also, the hydrazo-NH exists as hydrogen bonded to the keto-oxygen either as intra or as intermolecular hydrogen bonding. In all the studied complexes, all ligands behave as a neutral bidentate ligands with coordination involving the hydrazone-nitrogen and the keto-oxygen atoms. The magnetic and spectral data indicate a square planar geometry for Cu2+ complexes and an octahedral geometry for Ni2+ complexes. The ligands and their metal chelates have been screened for their antimicrobial activities using the disc diffusion method against the selected bacteria and fungi. They were found to be more active against Gram-positive than Gram-negative bacteria. It may be concluded that the antimicrobial activity of the compounds is related to cell wall structure of bacteria.Protonation constant of (PHP) ligand and stability constants of its Cu2+ and Ni2+ complexes were determined by potentiometric titration method in aqueous solution at ionic strength of 0.1 M sodium nitrate. It has been observed that the hydrazone ligand (PHP) titrated here has one protonation constant. The divalent metal ions Cu2+ and Ni2+ form with (PHP) 1:1 and 1:2 complexes. The insolubility of (THP) and (CHP) ligands in aqueous medium does not permit the determination of their protonation constants and formation constants of the corresponding complexes in aqueous solution. (c) 2009 Elsevier B.V. All rights reserved.
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐